Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Ebeling

Showing results (41-50 of 63) with videos related to

Pageof 7
Sort By:
Human Immunology|March 26, 2008
The clinical significance of soluble human leukocyte antigen class-I, ICTP, and RANKL molecules in multiple myeloma patientsPhilipp Schütt, Vera Rebmann, Dieter Brandhorst, et al.
Journal of Cancer Research and Clinical Oncology|October 21, 2006
Evaluation of different protocols for gene transfer into non-obese diabetes/severe combined immunodeficiency disease mouse repopulating cellsPeter Ebeling, P Bach, U Sorg, et al.
Annals of Hematology|March 4, 2005
Thalidomide in combination with dexamethasone for pretreated patients with multiple myeloma: serum level of soluble interleukin-2 receptor as a predictive factor for response rate and for survivalPhilipp Schütt, Peter Ebeling, Ulrike Buttkereit, et al.
Australian Family Physician|December 9, 2004
Guidelines for the management of postmenopausal osteoporosis for GPsSheila O'Neill, Alastair MacLennan, Shona Bass, et al.
Clinical Nutrition (Edinburgh, Scotland)|March 11, 2019
Longitudinal associations between dietary inflammatory index and musculoskeletal health in community-dwelling older adultsMavil May Cervo, Nitin Shivappa, James R Hebert, et al.
Cancer Research|September 19, 2007
A novel nonobese diabetic/severe combined immunodeficient xenograft model for chronic lymphocytic leukemia reflects important clinical characteristics of the diseaseJan Dürig, Peter Ebeling, Florian Grabellus, et al.
BMJ Open|April 5, 2022
Why Aboriginal and Torres Strait Islander Australians fall and fracture: the codesigned Study of Indigenous Muscle and Bone Ageing (SIMBA) protocolAyse Zengin, Cat Shore-Lorenti, Marc Sim, et al.
European Journal of Haematology|June 23, 2011
Investigating the role of CD38 and functionally related molecular risk factors in the CLL NOD/SCID xenograft modelSemra Aydin, Florian Grabellus, Lewin Eisele, et al.
Leukemia & Lymphoma|September 13, 2006
Immune parameters in multiple myeloma patients: influence of treatment and correlation with opportunistic infectionsPhilipp Schütt, Dieter Brandhorst, Werner Stellberg, et al.
Australian Family Physician|October 31, 2002
Guidelines for the treatment of postmenopausal osteoporosis for general practitionersSheila O'Neill, Philip Sambrook, Terry Diamond, et al.
Pageof 7

Showing results (41-50 of 63) with videos related to

Sort By:
Pageof 7
Human Immunology|March 26, 2008
The clinical significance of soluble human leukocyte antigen class-I, ICTP, and RANKL molecules in multiple myeloma patientsPhilipp Schütt, Vera Rebmann, Dieter Brandhorst, et al.
Journal of Cancer Research and Clinical Oncology|October 21, 2006
Evaluation of different protocols for gene transfer into non-obese diabetes/severe combined immunodeficiency disease mouse repopulating cellsPeter Ebeling, P Bach, U Sorg, et al.
Annals of Hematology|March 4, 2005
Thalidomide in combination with dexamethasone for pretreated patients with multiple myeloma: serum level of soluble interleukin-2 receptor as a predictive factor for response rate and for survivalPhilipp Schütt, Peter Ebeling, Ulrike Buttkereit, et al.
Australian Family Physician|December 9, 2004
Guidelines for the management of postmenopausal osteoporosis for GPsSheila O'Neill, Alastair MacLennan, Shona Bass, et al.
Clinical Nutrition (Edinburgh, Scotland)|March 11, 2019
Longitudinal associations between dietary inflammatory index and musculoskeletal health in community-dwelling older adultsMavil May Cervo, Nitin Shivappa, James R Hebert, et al.
Cancer Research|September 19, 2007
A novel nonobese diabetic/severe combined immunodeficient xenograft model for chronic lymphocytic leukemia reflects important clinical characteristics of the diseaseJan Dürig, Peter Ebeling, Florian Grabellus, et al.
BMJ Open|April 5, 2022
Why Aboriginal and Torres Strait Islander Australians fall and fracture: the codesigned Study of Indigenous Muscle and Bone Ageing (SIMBA) protocolAyse Zengin, Cat Shore-Lorenti, Marc Sim, et al.
European Journal of Haematology|June 23, 2011
Investigating the role of CD38 and functionally related molecular risk factors in the CLL NOD/SCID xenograft modelSemra Aydin, Florian Grabellus, Lewin Eisele, et al.
Leukemia & Lymphoma|September 13, 2006
Immune parameters in multiple myeloma patients: influence of treatment and correlation with opportunistic infectionsPhilipp Schütt, Dieter Brandhorst, Werner Stellberg, et al.
Australian Family Physician|October 31, 2002
Guidelines for the treatment of postmenopausal osteoporosis for general practitionersSheila O'Neill, Philip Sambrook, Terry Diamond, et al.
Pageof 7